InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
0.00%
)
Bitcoin
54,028.50
(
-0.26%
)
Post# of 253060
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 838
Posts 120392
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 113937

Thursday, 03/17/2011 5:45:31 PM

Thursday, March 17, 2011 5:45:31 PM

Post# of 253060
After losing in US court, LLY is arguing the Gemzar patent case against HSP before the ITC:

http://www.bloomberg.com/news/2011-03-17/lilly-claim-over-hospira-s-gemzar-copy-to-be-reviewed-by-itc-1-.html

Although unlikely, a recommendation by the ITC to impede the importation of generic Gemzar into the US would be a terrible precedent, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up